Results 221 to 230 of about 21,108 (240)

Dapagliflozin

Reactions Weekly, 2016
openaire   +2 more sources

Dapagliflozin

Reactions Weekly, 2022
openaire   +1 more source

Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2

Cell Reports Medicine, 2023
Tongtong Hu
exaly  

A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers: Applicability of a novel insulin-independent treatment

Diabetes Care, 2009
Paul Norwood, John Wilding
exaly  

Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium

Pharmacological Research, 2020
Konrad Urbanek, Carmela Dell'Aversana, Antonella de Angelis   +2 more
exaly  

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Diabetes Care, 2018
Paolo Di Bartolo, Julio Rosenstock, André Scheen   +2 more
exaly  

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Diabetes Care, 2018
Pieter Gillard, Marcus Lind, Chantal Mathieu   +2 more
exaly  

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

Diabetes, Obesity and Metabolism, 2018
Jochen Seufert, André Scheen, Serge Jabbour   +2 more
exaly  

Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes

Diabetes, Obesity and Metabolism, 2019
David W. Boulton, Peter J Greasley, Hiddo J L Heerspink   +2 more
exaly  

Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Diabetes Care, 2014
Serge Jabbour, Jennifer Sugg, Shamik Parikh   +2 more
exaly